Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1.06bn | 1.11bn | 1.06bn | 942m | 1.17bn | 998m |
| Cost of revenue | 649m | 687m | 644m | 570m | 701m | 623m |
| Gross profit | 410m | 427m | 417m | 372m | 472m | 376m |
| Research and development | 63m | 60m | 60m | 62m | 57m | 54m |
| Selling, general and administrative | 76m | 94m | 79m | 75m | 77m | 65m |
| Operating expenses | 293m | 324m | 305m | 288m | 304m | 272m |
| Operating income | 117m | 103m | 112m | 84m | 169m | 103m |
| Pre-tax income | 97m | 78m | 90m | 59m | 147m | 79m |
| Income tax | 24m | 12m | 15m | 14m | 33m | 20m |
| Net income | 73m | 66m | 74m | 44m | 114m | 59m |
| Earnings per share | 1.25 | 1.14 | 1.27 | 0.74 | 1.91 | 0.99 |
| Earnings per share, diluted | 1.24 | 1.12 | 1.25 | 0.73 | 1.89 | 0.97 |
| Weighted average shares | 58m | 58m | 58m | 59m | 59m | 60m |
| Weighted average shares, diluted | 59m | 59m | 59m | 60m | 60m | 61m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 266m | 341m | 300m | 224m | 187m | 281m | 214m | 218m |
| Receivables | 627m | 603m | 680m |
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 119m | — | — | 58m | — | — |
| Depreciation and amortisation | 26m | — | — |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)
| 649m |
| 590m |
| 612m |
| 659m |
| 610m |
| Inventory | 1.25bn | 1.25bn | 1.33bn | 1.25bn | 1.10bn | 1.03bn | 1.10bn | 1.15bn |
| Current assets | 2.45bn | 2.46bn | 2.50bn | 2.25bn | 1.99bn | 2.03bn | 2.07bn | 2.06bn |
| Property, plant and equipment | 820m | 814m | 779m | 767m | 710m | 690m | 640m | 623m |
| Goodwill | 1.49bn | 1.47bn | 1.47bn | 1.47bn | 1.44bn | 1.44bn | 1.45bn | 1.43bn |
| Total assets | 5.59bn | 5.57bn | 5.60bn | 5.39bn | 5.06bn | 5.11bn | 5.19bn | 5.12bn |
| Current liabilities | 1.21bn | 1.22bn | 1.15bn | 1.12bn | 1.01bn | 1.03bn | 1.02bn | 913m |
| Short-term debt | 44m | 51m | 46m | 54m | 57m | 56m | 66m | 66m |
| Long-term debt | 1.25bn | 1.26bn | 1.36bn | 1.29bn | 1.20bn | 1.21bn | 1.36bn | 1.44bn |
| Total liabilities | 2.92bn | 2.93bn | 2.95bn | 2.81bn | 2.59bn | 2.61bn | 2.77bn | 2.75bn |
| Equity | 2.67bn | 2.63bn | 2.64bn | 2.58bn | 2.47bn | 2.49bn | 2.41bn | 2.37bn |
| Shares outstanding | — | 74m | 74m | 74m | 74m | 74m | 74m | 74m |
| Shares issued | 74m | 74m | 74m | 74m | 74m | 74m | 74m | 74m |
| Treasury shares | 15m | 15m | 15m | 15m | 15m | 14m | 14m | 13m |
| 21m |
| — |
| — |
| Share-based compensation | 13m | 13m | 15m | 12m | 13m | 13m |
| Capital expenditure | 29m | 22m | 58m | 31m | 29m | 28m |
| Investing cash flow | −154m | — | — | −34m | — | — |
| Share buybacks | 0 | — | — | 97m | — | — |
| Financing cash flow | −41m | — | — | −120m | — | — |